Mesalamine Delayed-Release Tablets USP

Get a Price/Quote

MOQ : 100 Packs

Mesalamine Delayed-Release Tablets USP Specification

Indication
Ulcerative colitis, Crohns disease (as advised)

Dosage Form
Delayed-Release Tablet

Packaging Type
Blister Pack

Pacakaging (Quantity Per Box)
10 x 10 tablets

Salt Composition
Mesalamine USP 400 mg

Life Span
24 months from date of manufacturing

Drug Type
Allopathic

Ingredients
Mesalamine

Physical Form
Tablets

Function
Anti-inflammatory for gastrointestinal tract

Recommended For
For the treatment of mild to moderate ulcerative colitis

Dosage
As directed by the physician

Dosage Guidelines
Take with or without food, as advised by doctor

Suitable For
Adults

Quantity
100 tablets

Storage Instructions
Store in a cool, dry place, protected from light

Color
Light pink film-coated

Route of Administration
Oral

Regulatory Approval
Complies with USP specifications

Prescription/OTC Status
Prescription only

Common Side Effects
Headache, nausea, abdominal pain

Tablet Markings
Unscored

Contraindications
Hypersensitivity to salicylates or Mesalamine

Strength
400 mg per tablet

Shelf Packaging
Packed in aluminium foil strips inside a box

Mesalamine Delayed-Release Tablets USP Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Mesalamine Delayed-Release Tablets USP

Mesalamine Delayed-Release Tablets USP are optimized for superior anti-inflammatory efficacy in the treatment of mild to moderate ulcerative colitis. With a pristine light pink film-coating and each tablet containing 400 mg of Mesalamine, these prescription-only tablets deliver targeted relief while minimizing gastrointestinal side effects. Now available at a reduced price, you gain enhanced access to premium medication without compromising on safety or compliance, as it meets rigorous USP specifications. Packed securely in aluminium foil strips, these tablets preserve potency and quality, offering an optimum shelf life of 24 months. Discounted bulk quantities can be supplied for the Indian market.

Area Of Application and Use of Mesalamine Delayed-Release Tablets USP

Mesalamine Delayed-Release Tablets USP are primarily recommended for managing mild to moderate ulcerative colitis and, as advised by doctors, certain cases of Crohn's disease. These tablets are suitable for adult patients and are administered orally, typically as part of a prescribed regimen. Used as per physician instructions, they offer optimum gastrointestinal anti-inflammatory action, making them effective in both initial flare-ups and maintenance therapy. The delayed-release formulation provides targeted delivery to the affected regions, improving therapeutic results.

Delivery Time, FOB Port, and Payment Terms for Mesalamine Delayed-Release Tablets USP

Our Mesalamine Delayed-Release Tablets USP are shipped promptly, ensuring the lowest price for bulk orders within the export market. The standard delivery time falls between 2 to 4 weeks after receiving a confirmed Purchase Order. Shipments are generally dispatched from leading Indian FOB ports. Payment terms are designed for flexibility, accommodating Letters of Credit (L/C) or Telegraphic Transfer (T/T), making procurement efficient and buyer-friendly. Our export process ensures reliability and transparency for international clients.

FAQ's of Mesalamine Delayed-Release Tablets USP:

Q: How should Mesalamine Delayed-Release Tablets USP be taken for optimum benefit?

A: Mesalamine Delayed-Release Tablets USP should be taken orally with or without food, strictly following the dosage and duration prescribed by your physician for the most effective results.

Q: What conditions are treated with Mesalamine Delayed-Release Tablets USP?

A: These tablets are specifically indicated for the treatment of mild to moderate ulcerative colitis and can be used for certain cases of Crohn's disease as advised by your healthcare provider.

Q: When is Mesalamine Delayed-Release Tablets USP contraindicated?

A: Do not use this medication if you have known hypersensitivity to salicylates or Mesalamine itself. Always inform your doctor about any allergies before starting treatment.

Q: Where is Mesalamine Delayed-Release Tablets USP manufactured and exported from?

A: This product is manufactured and supplied by reputable traders in India, meeting USP specifications, and is available for export to various global markets.

Q: What is the process for placing a bulk Purchase Order for Mesalamine Delayed-Release Tablets?

A: To place a bulk order, simply contact our sales team, confirm the quantity and packaging, and process payment via accepted methods such as L/C or T/T. Orders are dispatched upon confirmation.

Q: What benefits does the delayed-release formulation of Mesalamine provide?

A: The delayed-release technology ensures the active ingredient is delivered directly to the site of inflammation in the gastrointestinal tract, improving therapeutic efficacy and reducing unwanted side effects.

Tell us about your requirement